https://www.hmpgloballearningnetwork.com/site/thederm/conference-coverage/rethinking-seborrheic-dermatitis-2026-pde4-inhibitors-luliconazole
Rethinking Seborrheic Dermatitis in 2026: PDE4 Inhibitors, Luliconazole, and Microbiome-Driven Care
A clinical update on seborrheic dermatitis, featuring roflumilast foam, luliconazole shampoo, JAK inhibitors, biologics, and microbiome-targeted therapies....
seborrheic dermatitisin 2026pde4 inhibitors